Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors

@article{Smith1998AgonistPO,
  title={Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors},
  author={Randy L. Smith and Herv{\'e} Canton and Robert John Barrett and Elaine sanders-Bush},
  journal={Pharmacology Biochemistry and Behavior},
  year={1998},
  volume={61},
  pages={323-330}
}
Extensive behavioral and biochemical evidence suggests an agonist role at the 5-HT2A receptor, and perhaps the 5-HT2C receptor, in the mechanism of action of hallucinogenic drugs. However the published in vitro pharmacological properties of N,N-dimethyltryptamine (DMT), an hallucinogenic tryptamine analog, are not consistent with this hypothesis. We, therefore, undertook an extensive investigation into the properties of DMT at 5-HT2A and 5-HT2C receptors. In fibroblasts transfected with the 5… Expand
The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice
TLDR
The 5-HT2AR likely plays a major role in mediating the effects of two tryptamine hallucinogenic drugs and likely modulate the discriminative stimulus effects of both compounds. Expand
5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice
TLDR
Data indicate that the decrease in locomotor activity induced by 10 mg/kg DOI is mediated by 5-HT2C receptors, an interpretation that is supported by the finding that the selective 5- HT2C agonist WAY 161,503 produces reductions in the locomotory activity that are potentiated in 5HT2A KO mice. Expand
Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats
TLDR
The induction of head-twitch response and potentiation of forepaw treading induced by 8-OH-DPAT indicate that hallucinogenic activity seems to be mediated through the stimulation of 5-HT2A and5-HT1A receptors by 5-MeO-DIPT. Expand
Inhibition of amino acid release by 5-HT1B receptor agonist in the rat prefrontal cortex.
TLDR
It is suggested that cortical glutamatergic neurons possess 5- HT1B heteroceptors and their activation may be responsible for the inhibitory effect of 5-HT on Glu and Asp release. Expand
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
TLDR
The evidence demonstrating that the effects of indoleamine hallucinogens in a variety of animal behavioral paradigms are mediated by both 5-HT(2) and non-5-HT (2) receptors is reviewed. Expand
A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity
N,N-dimethyltryptamine (DMT) is classified as a naturally occurring serotonergic hallucinogen of plant origin. It has also been found in animal tissues and regarded as an endogenous trace amineExpand
The Paradox of 5-Methoxy-N,N-Dimethyltryptamine An Indoleamine Hallucinogen That Induces Stimulus Control Via 5-HT1A Receptors
TLDR
It is concluded that 5-MeO-DMT differs from DOM with respect to the serotonergic element that mediates stimulus control in the rat, but that it shares with DOM a functionally significant interaction with 5-HT2 receptors. Expand
The hallucinogenic world of tryptamines: an updated review
TLDR
A comprehensive update on tryptamine hallucinogens, concerning their historical background, prevalence, patterns of use and legal status, chemistry, toxicokinetics, toxicodynamics and their physiological and toxicological effects on animals and humans is provided. Expand
Chapter 15 – Tryptamines
Tryptamines are a diverse group of 5HT2A agonist compounds. The predominant clinical effect produced by tryptamine exposure is hallucinations, mediated by agonism at 5HT2A and 5HT1A receptors.Expand
Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats
TLDR
The present results suggest that antagonists of the 5-HT5A receptor may inhibit subjective effects of LSD in rats. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 21 REFERENCES
Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.
TLDR
DMT has opposing actions on 5-HT receptor subtypes, displaying agonist activity at5-HT1A receptors and antagonist activity at 5- HT2 receptors, and these studies suggest that DMT has antagonistic properties at 4-HT2 receptors. Expand
Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.
TLDR
LSD partially antagonized the effect of 5-HT in the choroid plexus, consistent with a partial agonist effect at the 5- HT-1c receptor in this tissue. Expand
m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts.
Serotonin2A (5-HT2A) and 5-HT2C receptors share numerous pharmacological properties. Two compounds thought to discriminate between these two receptor subtypes are m-chlorophenypiperazine (mCPP) andExpand
Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.
TLDR
5-HT2C receptor neutral antagonists exhibited functional and receptor binding properties consistent with those of classical receptor antagonists, however, 5-HT 2C receptor inverse agonists displayed functional and receptors binding properties that were opposite those of agonists. Expand
Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.
TLDR
The data indicate that MDL 100,907 has a clozapine-like profile of potential antipsychotic activity with low extrapyramidal sid-effect liability. Expand
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
TLDR
The results of this study suggest that the mechanism of action of these agents involves 5-HT2-related events. Expand
Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist.
TLDR
It would appear that the DOM stimulus is primarily a 5-HT2-mediated, and not 5- HT1C- mediated, phenomenon, and compound 26 may find application in other pharmacologic investigations where spiperone may not be a suitable antagonist. Expand
Pharmacological activity of the isomers of LY53857, potent and selective 5-HT2 receptor antagonists.
TLDR
The present study investigated the activities of the diastereomers of LY53857 and found that a similar profile of selectivity was demonstrated for each of the isomers studied, with the meso mixture of isomers being slightly less potent than the SS- and RR-isomers after p.o.v. administration of serotonin. Expand
Human psychopharmacology of N,N-dimethyltryptamine
  • R. Strassman
  • Medicine, Psychology
  • Behavioural Brain Research
  • 1995
TLDR
DMT remains unique among classic hallucinogens in its inability to induce tolerance to its psychological effects, suggesting a buffering effect of 5- HT1A agonism on 5-HT2-mediated psychedelic effects. Expand
Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
TLDR
The combined results from the substitution, antagonism and ex vivo receptor autoradiographic studies suggest that the discriminative stimuli of quipazine and ketanserin are mediated at least in part by the 5-HT2A receptor. Expand
...
1
2
3
...